stockrowGlaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.
- Revenue
- +58.0%
- EPS
- +110.7%
- Free cash flow
- +411.2%
- Total debt
- −2.25%
Quarter to September 2026, against a year earlier
Follow GKOS
Alert me
Glaukos Corporation (GKOS) Return on assets
Glaukos Corporation's return on assets over the twelve months to 30 September 2026 was −17.2%, up 2.9 percentage points from fiscal 2025 (−20.1%). Over the past ten years it has ranged from −52.2% (fiscal 2015) to 3.60% (fiscal 2016); the current reading is higher than 18% of that period. That is in line with the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −20.1% | (4.80) |
| FY2024 | −15.3% | (1.43) |
| FY2023 | −13.9% | (4.19) |
| FY2022 | −9.67% | (4.84) |
| FY2021 | −4.83% | 8.37 |
| FY2020 | −13.2% | (16.21) |
| FY2019 | 3.01% | 9.96 |
| FY2018 | −6.95% | (6.89) |
| FY2017 | −0.06% | (3.66) |
| FY2016 | 3.60% | 55.80 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| PODD Insulet Corporation compare | 13.3% |
| GMED Globus Medical, Inc. compare | 10.5% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 9.99% |
| BIO Bio-Rad Laboratories, Inc. compare | 9.99% |
| PEN Penumbra, Inc. compare | 8.33% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.26% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| BRKR Bruker Corporation compare | −2.73% |
| GKOS Glaukos Corporation | −17.2% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on GKOS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement